TN2013000102A1 - Pyrazine derivatives as enac blockers - Google Patents

Pyrazine derivatives as enac blockers

Info

Publication number
TN2013000102A1
TN2013000102A1 TNP2013000102A TN2013000102A TN2013000102A1 TN 2013000102 A1 TN2013000102 A1 TN 2013000102A1 TN P2013000102 A TNP2013000102 A TN P2013000102A TN 2013000102 A TN2013000102 A TN 2013000102A TN 2013000102 A1 TN2013000102 A1 TN 2013000102A1
Authority
TN
Tunisia
Prior art keywords
compounds
pyrazine derivatives
enac blockers
enac
blockers
Prior art date
Application number
TNP2013000102A
Other languages
English (en)
Inventor
Gurdip Bhalay
Lee Edwards
Catherine Howsham
Peter Hunt
Nichola Smith
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2011/066151 external-priority patent/WO2012035158A1/fr
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2013000102A1 publication Critical patent/TN2013000102A1/fr

Links

TNP2013000102A 2011-09-16 2013-03-12 Pyrazine derivatives as enac blockers TN2013000102A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/066151 WO2012035158A1 (fr) 2010-09-17 2011-09-16 Dérivés de la pyrazine en tant que bloqueurs de l'enac

Publications (1)

Publication Number Publication Date
TN2013000102A1 true TN2013000102A1 (en) 2014-06-25

Family

ID=54360789

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000102A TN2013000102A1 (en) 2011-09-16 2013-03-12 Pyrazine derivatives as enac blockers

Country Status (1)

Country Link
TN (1) TN2013000102A1 (fr)

Similar Documents

Publication Publication Date Title
JO3064B1 (ar) مشتقات بيرازين كسادات ENaC
TN2015000281A1 (fr) Lactames condenses aryliques et heteroaryliques
PH12015501363A1 (en) Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
IN2014MN02598A (fr)
PH12014501542A1 (en) Substituted pyrrolidine -2- carboxamides
PH12015500457A1 (en) Alkoxy pyrazoles as soluble guanylate cyclase activators
MX2014012695A (es) Derivados de isoindolona.
UA109010C2 (en) MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY
JO3115B1 (ar) مركبات بيريدازينون واستخدامها كمثبطات daao
MX2013010898A (es) Novedoso derivados de la pirimidina.
MX351305B (es) Antagonistas del receptor de mineralocorticoides.
IN2015DN01119A (fr)
MD20160053A2 (ro) Derivaţi ai purinei 2,6-substituite şi utilizarea acestora în tratamentul tulburărilor proliferative
PH12015500063B1 (en) Azaindole derivatives which act as pi3k inhibitors
PH12015500111A1 (en) Difluorolactam compositions for ep4-mediated osteo related diseases and conditions
MD20160111A2 (ro) Derivaţi diheterociclici legaţi de cicloalchil
MX2015012600A (es) Compuestos de tetrahidroisoquinolina-2-il-(quinazolina-4-il) metanona como inhibidores del crecimiento de células cancerígenas.
TN2013000102A1 (en) Pyrazine derivatives as enac blockers
UA111595C2 (uk) ПІРАЗИНОВІ ПОХІДНІ ЯК ENaC БЛОКАТОРИ
TN2014000077A1 (en) Pyridazinone compounds and their use as daao inhibitors
CA2905957C (fr) Composes pyrazoles, compositions et methodes pour le traitement de maladies et de troubles degeneratifs